Revolutionising cancer diagnosis: Greenlight given for new blood test

  • Home
  • /
  • Podcasts
  • /
  • Revolutionising cancer diagnosis: Greenlight given for new blood test - 03 Jan 17
Ed Bowsher

Revolutionising cancer diagnosis: Greenlight given for new blood test

Ed Bowsher
Original Broadcast:

News Hour

Revolutionising cancer diagnosis: Greenlight given for new blood test
Last September Share Radio's Ed Bowsher spoke to Cameron Reynolds, CEO of VolitionRX - a diagnostics company developing blood tests for cancer. Current methods for detecting cancer tend to be inaccurate or people simply don't take them, but Volition hopes blood-based tests can pave the way forward. Cameron joined Ed back in the studio to announce some good news for his business: VolitionRX has received its first CE Mark, meaning that it is legally allowed to sell its products in Europe.

Published:


Listen
View all podcasts